Axial spondyloarthritis and inflammatory bowel disease: Therapeutic implications

被引:0
|
作者
Goupille, Philippe [1 ,2 ,6 ]
Vuitton, Lucine [3 ,4 ]
Wendling, Daniel [5 ]
机构
[1] CHU Tours, Rheumatol Dept, Tours, France
[2] Univ Tours, CNRS, UPR 4301, NMNS,CBM, Tours, France
[3] CHU Besancon, Gastroenterol Dept, Besancon, France
[4] Univ Franche Comte, Inserm, UMR RIGHT, Besancon, France
[5] Univ Franche Comte, CHU Besancon, Rheumatol Dept, EA 4266, Besancon, France
[6] CHU Tours, Trousseau Hosp, Rheumatol Dept, F-37044 Tours 9, France
关键词
Axial spondyloarthritis; Inflammatory bowel disease; Treatment; MAINTENANCE THERAPY; INDUCTION; GUIDELINES;
D O I
10.1016/j.jbspin.2024.105720
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页数:4
相关论文
共 50 条
  • [41] Apoptosis of T cells and the control of inflammatory bowel disease: therapeutic implications
    Mudter, J.
    Neurath, M. F.
    GUT, 2007, 56 (02) : 293 - 303
  • [42] Sclerostin and Antisclerostin Antibody Serum Levels Predict the Presence of Axial Spondyloarthritis in Patients with Inflammatory Bowel Disease
    Luchetti, Michele Maria
    Ciccia, Francesco
    Avellini, Chiara
    Benfaremo, Devis
    Guggino, Giuliana
    Farinelli, Alessia
    Ciferri, Monia
    Rossini, Matteo
    Svegliati, Silvia
    Spadoni, Tatiana
    Bolognini, Laura
    Fava, Giammarco
    Mosca, Piergiorgio
    Gesuita, Rosaria
    Skrami, Edlira
    Triolo, Giovanni
    Gabrielli, Armando
    JOURNAL OF RHEUMATOLOGY, 2018, 45 (05) : 630 - 637
  • [43] Mucosal healing and inflammatory bowel disease: Therapeutic implications and new targets
    Megan Lynn Otte
    Raju Lama Tamang
    Julia Papapanagiotou
    Rizwan Ahmad
    Punita Dhawan
    Amar B Singh
    World Journal of Gastroenterology, 2023, (07) : 1157 - 1172
  • [44] Inflammatory bowel disease and smoking -: A review of epidemiology, pathophysiology, and therapeutic implications
    Birrenbach, T
    Böcker, U
    INFLAMMATORY BOWEL DISEASES, 2004, 10 (06) : 848 - 859
  • [45] Mucosal healing and inflammatory bowel disease: Therapeutic implications and new targets
    Otte, Megan Lynn
    Tamang, Raju Lama
    Papapanagiotou, Julia
    Ahmad, Rizwan
    Dhawan, Punita
    Singh, Amar B.
    WORLD JOURNAL OF GASTROENTEROLOGY, 2023, 29 (07) : 1157 - 1172
  • [46] Adhesion molecules in inflammatory bowel disease: Therapeutic implications for gut inflammation
    Danese, S
    Semeraro, S
    Marini, M
    Roberto, I
    Armuzzi, A
    Papa, A
    Gasbarrini, A
    DIGESTIVE AND LIVER DISEASE, 2005, 37 (11) : 811 - 818
  • [47] miRNA effects on gut homeostasis: therapeutic implications for inflammatory bowel disease
    Dhuppar, Shivnarayan
    Murugaiyan, Gopal
    TRENDS IN IMMUNOLOGY, 2022, 43 (11) : 917 - 931
  • [48] Prevalence of spondyloarthritis in Turkish patients with inflammatory bowel disease
    Beslek, Asli
    Onen, Fatos
    Birlik, Merih
    Akarsu, Mesut
    Akar, Servet
    Sari, Ismail
    Gurler, Oguz
    Akpinar, Hale
    Manisali, Metin
    Akkoc, Nurullah
    RHEUMATOLOGY INTERNATIONAL, 2009, 29 (08) : 955 - 957
  • [49] Inflammatory bowel disease manifestations in spondyloarthritis: considerations for the clinician
    Lubrano, Ennio
    Luchetti, Michele Maria
    Benfaremo, Devis
    Mauro, Daniele
    Ciccia, Francesco
    Perrotta, Fabio Massimo
    EXPERT REVIEW OF CLINICAL IMMUNOLOGY, 2021, 17 (11) : 1199 - 1209
  • [50] Prevalence of spondyloarthritis in Turkish patients with inflammatory bowel disease
    Asli Beslek
    Fatos Onen
    Merih Birlik
    Mesut Akarsu
    Servet Akar
    Ismail Sari
    Oguz Gurler
    Hale Akpinar
    Metin Manisali
    Nurullah Akkoc
    Rheumatology International, 2009, 29 : 955 - 957